Tuesday, October 6, 2026
The Cancer News

AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER

Dr. Dikshat Gupta

Dr. Dikshat Gupta

the Department of Urology, Feinberg School of Medicine, Northwestern University

Dr. Gupta earned his master's degree in Human Genomics from Panjab University, Chandigarh, India, before pursuing his PhD in hematological malignancies at the Post Graduate Institute of Medical Education and Research. His work has resulted in 12-13 publications specifically on Ph-like ALL cases, establishing him as a leading voice in this field. His work has earned him the Asia’s Best Researcher of the Year Award in Hematology/Genetic Subtypes of Leukemia/PROTACS for treatment of MLL-Rearranged Leukemia in 2024 and many national and international recognitions like Young Researcher Award, Prestigious Dr J.C. Patel, ASH Abstract Achievement Award, and PHi-RACE best innovation award (2020-2024).

At Feinberg School of Medicine, under the mentorship of Dr. Sarki A. Abdulkadir, Dr. Gupta continues to advance leukemia research, currently focusing on the development of PROTACs (proteolysis-targeting chimeras) for treating aggressive forms of leukemia. His work also extends to investigating the role of biology in both hematologic and solid tumors.


Published Articles (1)

$40 Test Could Save Lives: Researcher Cracks Code on Aggressive Leukemia Affecting One-Third of Asian Patients

October 27, 2025

Dr. Dikshat Gupta’s $40 diagnostic test for Ph-like ALL offers a groundbreaking, affordable solution to detect aggressive leukemia subtypes common in Asian populations, advancing equitable cancer care.